British Journal of Cancer

FIGURE 1

FROM:

Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients

T Nousiainen, E Jantunen, E Vanninen and J Hartikainen

BACK TO ARTICLE

Figure 1.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Changes in left ventricular ejection (LVEF) during doxorubicin therapy. (A) represents data of all patients, and (B) represents data without and with the decrease in LVEF greater than or equal to10% units to the final LVEF less than or equal to50%. *P<0.05, ** P<0.01, ***P<0.001 vs baseline.

BACK TO ARTICLE